Virtual Reality Therapy for Cancer-Treatment Associated Symptoms

Summary

We propose an innovative approach to symptom management in cancer patients following cancer treatments, utilizing a Multimodal Integrative Therapy (MIT) delivered via Virtual Reality (VR) program, authorized by the US Food and Drug Administration for in-home use. Our primary goal is to generate pilot data on the effects of MIT-VR program on pain, fatigue, sleep, depression, and anxiety in participants suffering from chronic cancer symptoms following cancer treatments.

Eligibility

Inclusion Criteria:

* Adults ages 18-88
* Cancer diagnosis (histology verified)
* Had surgical intervention, completed chemotherapy or radiation for therapeutic purposes

  -\>3 months since last cancer treatment, but participants currently undergoing endocrine or immunotherapy treatments are permissible
* Documented symptoms of cancer or cancer therapy including at least one of the following: pain, anxiety, sleep difficulty, fatigue, neuropathy
* English speaker (written and spoken)

Exclusion Criteria:

* Severe psychiatric condition (e.g. schizophrenia, bipolar disorders, autism) leading to hospitalization within the last 3 years
* Any personal (or family first degree) history of mania, schizophrenia, or other psychoses
* Diagnosis and treatment of chronic pain, neuropathy, fatigue, sleep or anxiety disorder prior to cancer diagnosis
* Current Hospice or palliative care only recipients
* Color-blindness
* Impaired or uncorrected hearing
* Lifetime alcohol/drug dependence or alcohol/drug abuse in past 3 months
* Conditions that would interfere with the VR mask placement (e.g. trauma, burn, infection)
* Known history of severe motion sickness
* Pregnancy or breast feeding

Conditions3

Locations2 sites

Browse More Trials